RecruitMe Clinical Trial

A Placebo-Controlled Study to Evaluate the Effect of a Single Dose of CVN058-103 on Mismatch Negativity in Subjects with Stable Schizophrenia
CVN058 Effect on Mismatch Negativity in Schizophrenics
Sponsor:Cerevance
Enrolling:Male and Female Patients
Age Range:Between 18 and 50 years old
IRB Number:7677
U.S. Government ID:NCT03669250
Contact: Marlene Carlson, MPH: 646-774-8436 / mc157@columbia.edu
Additional Study Information:

The purpose of this study is to determine whether the brain wave patterns are improved after administration of CVN058 compared to placebo in subjects with schizophrenia. The study uses electroencephalography (EEG) to measure naturally occurring brain waves as you listen to recorded sounds.

Do You Qualify?
Do you have schizophrenia?YesNo
Are you between the ages of 18-50?YesNo
Are you / have you been on Clozapine?YesNo
Submit
Cancel
Investigator
Dr. Joshua Kantrowitz
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Marlene Carlson, MPH
Email: mc157@columbia.edu
Phone: 646-774-8436